Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia

Sean James Judge, Trevor A. Plescia, Cyrus Bateni, Morgan Darrow, Christopher P Evans, Robert J Canter

Research output: Contribution to journalArticle

Abstract

Ataxia–telangiectasia confers a significant increase in the development of several cancer types, most commonly leukemia and lymphoma. However, as the natural history for these patients is evolving and their lifespan is increasing, there is the potential for the development of additional uncommon tumors in an already rare patient population. We report the first case, to our knowledge, of an incidental retroperitoneal tumor in a 26-year-old woman undergoing evaluation for hepatic dysfunction. The mass was suspicious for retroperitoneal sarcoma, but proved to be an extramedullary hematopoietic pseudotumor after extensive pathologic evaluation. The changing landscape of neoplasms associated with ataxia–telangiectasia is discussed with emphasis on previously underreported benign and malignant tumors.

Original languageEnglish (US)
JournalRare Tumors
Volume10
DOIs
StatePublished - Jul 21 2018

Keywords

  • ataxia–telangiectasia
  • Extramedullary hematopoietic pseudotumor
  • retroperitoneal sarcoma

ASJC Scopus subject areas

  • Histology
  • Oncology

Fingerprint Dive into the research topics of 'Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia'. Together they form a unique fingerprint.

  • Cite this